Rheumatology in Russia in the early 21st century

Rheumatoid arthritis (RA) is the most common immune inflammatory rheumatic disease. The paper gives the current data of Russian investigations into the early diagnosis of RA and into innovative approaches to its therapy.

Bibliographic Details
Published in:	Терапевтический архив
Main Author:	E L Nasonov
Format:	Article
Language:	Russian
Published:	"Consilium Medicum" Publishing house 2013-05-01
Subjects:	rheumatoid arthritis inflammation genetically engineered biological agents
Online Access:	https://ter-arkhiv.ru/0040-3660/article/view/31248

Similar Items

BIOSIMILARS IN RHEUMATOLOGY
by: E. L. Nasonov
Published: (2017-01-01)

Safety of using genetic engineering biological agents in rheumatoid arthritis
by: N V Chichasova, et al.
Published: (2010-03-01)

USE OF THE NEW GENETIC ENGINEERING BIOLOGICAL AGENT TOCILIZUMABIN THE TREATMENT OF RHEUMATOID ARTHRITIS
by: E L Nasonov, et al.
Published: (2010-03-01)

Severe rheumatoid arthritis with multiple baseline anti-inflammatory drugs intolerance
by: D. A. Kusevich, et al.
Published: (2016-12-01)

Progress in rheumatology in the early 21st century
by: E. L. Nasonov
Published: (2014-09-01)

INTERLEUKIN-17 IS A NEW TARGET FOR ANTI-CYTOKINE THERAPY OF IMMUNE INFLAMMATORY RHEUMATIC DISEASES
by: Evgeny Lvovich Nasonov, et al.
Published: (2013-12-01)

Combination therapy with leflunomide and genetic engineering biological agents
by: Nataliya Vladimirovna Chichasova, et al.
Published: (2011-06-01)

The progress of rheumatology in the 21st century potential uses of upadacitinib in rheumatoid arthritis and other inflammatory rheumatic diseases
by: E. L. Nasonov, et al.
Published: (2020-11-01)

ACHIEVEMENTS IN RHEUMATOLOGY IN THE XXI CENTURY
by: E. L. Nasonov
Published: (2014-06-01)

Infliximab in Russian clinical practice
by: G V Lukina, et al.
Published: (2012-09-01)

METHOTREXATE IN RHEUMATOID ARTHRITIS – 2015: NEW FACTS AND IDEAS
by: E. L. Nasonov
Published: (2015-09-01)

METHOTREXATE IN RHEUMATOID ARTHRITIS – 2015: NEW FACTS AND IDEAS
by: E. L. Nasonov
Published: (2016-12-01)

PHARMACOTHERAPY FOR RHEUMATOID ARTHRITIS: NEW STRATEGY, NEW TARGETS
by: E. L. Nasonov
Published: (2017-09-01)

METHOTREXATE IN RHEUMATOID ARTHRITIS – 2015: NEW FACTS AND IDEAS
by: E. L. Nasonov
Published: (2015-10-01)

RHEUMATOID ARTHRITIS: PROBLEMS AND SIGNIFICANCE OF PERSONALIZED MEDICINE
by: E L Nasonov
Published: (2012-05-01)

Pharmacotherapy for rheumatoid arthritis in the early 21st century: Russian and international experience
by: E L Nasonov, et al.
Published: (2013-08-01)

Autoimmunity in rheumatology: A review
by: Evgeny L. Nasonov
Published: (2023-12-01)

PHARMACOTHERAPY FOR RHEUMATOID ARTHRITIS: RUSSIAN AND INTERNATIONAL GUIDELINES
by: E. L. Nasonov
Published: (2016-12-01)

THE EUROPEAN CONGRESS OF RHEUMATOLOGY (PARIS, 11–14 JUNE 2014): PROBLEMS OF RHEUMATOID ARTHRITIS
by: A. S. Avdeeva, et al.
Published: (2014-12-01)

Experience with abatacept used in the treatment of patients with rheumatoid arthritis
by: V I Mazurov, et al.
Published: (2011-12-01)

ROLE OF MATRIX METALLOPROTEINASE 3 IN PREDICTING THE EFFICIENCY OF THERAPY FOR EARLY RHEUMATOID ARTHRITIS: THE REMARCA TRIAL
by: A. S. Avdeeva, et al.
Published: (2016-03-01)

RHEUMATOID ARTHRITIS IN RHEUMATOLOGICAL CARE OF RUSSIA: THE SEVERITY OF THE DISEASE IN A RUSSIAN PATIENT POPULATION: A CROSS-SECTIONAL EPIDEMIOLOGICAL STUDY (RAISER)
by: O M Folomeeva, et al.
Published: (2010-02-01)

WHY ARE THE RECOMMENDED METHOTREXATE DOSES NOT USED FOR THE TREATMENT OF RHEUMATOID ARTHRITIS: WHO IS GUILTY AND WHAT TO DO?
by: Yu. V. Muravyev, et al.
Published: (2017-03-01)

Influence of biologics on carbohydrate metabolism and risk of diabetes
by: L. V. Kondratieva, et al.
Published: (2019-05-01)

Personalized medicine in rheumatology
by: Anna Kłak, et al.
Published: (2016-10-01)

A CURRENT VIEW ON THE PROBLEM OF RAPIDLY PROGRESSIVE RHEUMATOID ARTHRITIS
by: Dmitry Evgenyevich Karateyev
Published: (2010-06-01)

ORTHOPEDIC RHEUMATOLOGY IN RUSSIA: HISTORY AND CONTEMPORANEITY
by: V. P. Pavlov
Published: (2020-06-01)

The first Russian strategic study of pharmacotherapy for rheumatoid arthritis (REMARCA)
by: Dmitri Evgenyevich Karateev, et al.
Published: (2013-04-01)

CARDIOVASCULAR DISEASES IN RHEUMATOID ARTHRITIS: LATEST DATA
by: T. V. Popkova, et al.
Published: (2016-07-01)

Advances in pharmacotherapy for immunoinflammatory rheumatic diseases in the 21st century
by: Evgeny L. Nasonov
Published: (2025-01-01)

EUROPEAN CONGRESS OF RHEUMATOLOGY (MADRID, 12–15 JUNE 2013): PROBLEMS ON RHEUMATOID ARTHRITIS
by: Anastasia Sergeevna Avdeeva, et al.
Published: (2013-12-01)

POSSIBILITIES FOR PRESERVING THE RESULTS OF TREATMENT IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS AFTER DOSE REDUCTION AND/OR DISCONTINUATION OF BIOLOGICAL AGENTS: A REMARCA STUDY
by: E. L. Luchikhina, et al.
Published: (2016-12-01)

CLINICAL SIGNIFICANCE OF BAFF/BLyS AND APRIL IN SYSTEMIC LUPUS ERYTHEMATOSUS AND RHEUMATOID ARTHRITIS
by: E. V. Suponitskya, et al.
Published: (2014-10-01)

Interstitial lung disease in rheumatoid arthritis: A multidisciplinary problem in rheumatology and pulmonology
by: E. L. Nasonov, et al.
Published: (2022-12-01)

Interstitial lung disease in rheumatoid arthritis: A multidisciplinary problem in rheumatology and pulmonology
by: E. L. Nasonov, et al.
Published: (2018-06-01)

«Gastroenterological» rheumatology: differential diagnosis of early arthritis
by: E. A. Galushko, et al.
Published: (2019-09-01)

Experience with long-term use of certolizumab pegol (Cimzia)
by: Karine Arnoldovna Lytkina, et al.
Published: (2013-10-01)

Experience with long-term use of certolizumab pegol (Cimzia)
by: Karine Arnoldovna Lytkina, et al.
Published: (2013-10-01)

THE EUROPEAN CONGRESS OF RHEUMATOLOGY, ROME (10–13 JUNE 2015): PROBLEMS OF RHEUMATOID ARTHRITIS
by: A. S. Avdeeva, et al.
Published: (2016-02-01)

The influence of CCPA and RF on the five-year outcomes in patients with early rheumatoid arthritisиве
by: Ermakova Yu.A., et al.
Published: (2015-06-01)